Question 1

How does Ephedra equisetina work as a bronchodilator?

Accepted Answer

Ephedra equisetina contains ephedrine and pseudoephedrine, which act as sympathomimetic amines. These compounds stimulate alpha and beta-adrenergic receptors, causing relaxation of bronchial smooth muscle and bronchodilation. Ephedrine also promotes norepinephrine release, enhancing airway opening. This dual mechanism makes it effective for respiratory conditions like asthma. The bronchodilatory effect typically begins within 30-60 minutes of oral administration. Evidence level: C, based on pharmacological studies and traditional use.

Question 2

What are the drug interactions of Ephedra equisetina?

Accepted Answer

Ephedra equisetina has significant drug interactions due to its ephedrine content. It should never be combined with MAO inhibitors, as this can cause hypertensive crisis. Concurrent use with stimulants like caffeine or decongestants increases cardiovascular risks. Ephedra may reduce beta-blocker and antihypertensive medication effectiveness. It can interact with cardiac glycosides, increasing arrhythmia risk. Patients taking thyroid medications, diabetes drugs, or antidepressants should avoid Ephedra. Always consult a healthcare provider before combining with prescription medications.

Question 3

What is the recommended dosage for Ephedra equisetina?

Accepted Answer

The typical adult dosage for Ephedra equisetina is 1-3 grams of dried herb daily, prepared as a decoction. This dosage is regulated in many countries due to ephedrine content. Standardized preparations typically provide 15-30mg ephedrine per dose. Use should be limited to short-term applications (no more than 7 days) and under professional supervision. Higher doses significantly increase adverse cardiovascular effects. Evidence level: C, Traditional use. Regulatory restrictions apply in many jurisdictions.

Question 4

Is Ephedra equisetina safe during pregnancy?

Accepted Answer

Ephedra equisetina is unsafe during pregnancy and breastfeeding. Ephedrine crosses the placenta and may cause fetal tachycardia and developmental concerns. During breastfeeding, ephedrine passes into breast milk, potentially causing irritability and sleep disturbances in nursing infants. The herb's uterine-stimulating properties pose additional risk of premature labor. Pregnant individuals with respiratory conditions should seek alternative treatments under medical supervision. Ephedra is contraindicated throughout pregnancy and lactation.

Question 5

What are the side effects of Ephedra equisetina?

Accepted Answer

Ephedra equisetina can cause significant cardiovascular and central nervous system side effects. Common effects include elevated blood pressure, tachycardia, palpitations, anxiety, insomnia, and headache. More serious adverse effects include cardiac arrhythmias, myocardial infarction, and stroke, particularly at higher doses or with prolonged use. Individuals with cardiovascular disease, hypertension, or anxiety disorders face increased risk. Due to these safety concerns, Ephedra products are regulated or banned in several countries. Evidence level: C.

Ephedra equisetina

Sources & Citations

Callistemon citrinus

Balsam of Peru

Reindeer Lichen

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Evidence summary

PubMed sources

Government sources